BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18687376)

  • 1. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.
    Crettol S; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Déglon JJ; Preisig M; Eap CB
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1722-7. PubMed ID: 18687376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preliminary study: novelty seeking, frontal executive function, and dopamine receptor (D2) TaqI A gene polymorphism in patients with methamphetamine dependence.
    Han DH; Yoon SJ; Sung YH; Lee YS; Kee BS; Lyoo IK; Renshaw PF; Cho SC
    Compr Psychiatry; 2008; 49(4):387-92. PubMed ID: 18555060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effect of promoter polymorphisms in the dopamine D4 receptor and the serotonin transporter genes in heroin dependence.
    Szilagyi A; Boór K; Székely A; Gaszner P; Kalász H; Sasvári-Székely M; Barta C
    Neuropsychopharmacol Hung; 2005 Mar; 7(1):28-33. PubMed ID: 16167465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.
    Doehring A; Hentig Nv; Graff J; Salamat S; Schmidt M; Geisslinger G; Harder S; Lötsch J
    Pharmacogenet Genomics; 2009 Jun; 19(6):407-14. PubMed ID: 19373123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between polymorphisms of dopamine receptors, type D2, and bipolar affective illness in a Polish population.
    Leszczyńska-Rodziewicz A; Hauser J; Dmitrzak-Weglarz M; Skibińka M; Czerski P; Zakrzewska A; Kosmowska M; Rybakowski JK
    Med Sci Monit; 2005 Jun; 11(6):CR289-295. PubMed ID: 15917720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
    Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association of dopamine receptor sensitivity in vivo with genetic predisposition for alcoholism and DRD2/DRD3 gene polymorphisms in alcohol dependence.
    Wiesbeck GA; Dürsteler-MacFarland KM; Wurst FM; Walter M; Petitjean S; Müller S; Wodarz N; Böning J
    Addict Biol; 2006 Mar; 11(1):72-5. PubMed ID: 16759339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals.
    Coller JK; Barratt DT; Dahlen K; Loennechen MH; Somogyi AA
    Clin Pharmacol Ther; 2006 Dec; 80(6):682-90. PubMed ID: 17178268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential association of DRD2 and DAT1 genetic variation with heroin dependence.
    Hou QF; Li SB
    Neurosci Lett; 2009 Oct; 464(2):127-30. PubMed ID: 19664686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments.
    Barratt DT; Coller JK; Somogyi AA
    Am J Med Genet B Neuropsychiatr Genet; 2006 Jun; 141B(4):323-31. PubMed ID: 16583408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis.
    Ujike H; Katsu T; Okahisa Y; Takaki M; Kodama M; Inada T; Uchimura N; Yamada M; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):625-9. PubMed ID: 19275926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of the delta-opioid receptor gene to heroin abuse in a large Chinese case/control sample.
    Xu K; Liu XH; Nagarajan S; Gu XY; Goldman D
    Am J Med Genet; 2002 Jun; 110(1):45-50. PubMed ID: 12116270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DRD2 gene 957C>T polymorphism is associated with posttraumatic stress disorder in war veterans.
    Voisey J; Swagell CD; Hughes IP; Morris CP; van Daal A; Noble EP; Kann B; Heslop KA; Young RM; Lawford BR
    Depress Anxiety; 2009; 26(1):28-33. PubMed ID: 18833581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Male limited association of the dopamine receptor D2 gene TaqI a polymorphism and alcohol dependence.
    Limosin F; Gorwood P; Loze JY; Dubertret C; Gouya L; Deybach JC; Adès J
    Am J Med Genet; 2002 Nov; 112(4):343-6. PubMed ID: 12376935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients.
    Hung CC; Chiou MH; Huang BH; Hsieh YW; Hsieh TJ; Huang CL; Lane HY
    Pharmacogenomics; 2011 Nov; 12(11):1525-33. PubMed ID: 21902500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action.
    Lötsch J; Skarke C; Wieting J; Oertel BG; Schmidt H; Brockmöller J; Geisslinger G
    Clin Pharmacol Ther; 2006 Jan; 79(1):72-89. PubMed ID: 16413243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF variability in opioid addicts and response to methadone treatment: preliminary findings.
    de Cid R; Fonseca F; Gratacòs M; Gutierrez F; Martín-Santos R; Estivill X; Torrens M
    Genes Brain Behav; 2008 Jul; 7(5):515-22. PubMed ID: 18182069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients.
    Wang SC; Tsou HH; Chen CH; Chen YT; Ho IK; Hsiao CF; Chou SY; Lin YF; Fang KC; Huang CL; Su LW; Fang YC; Liu ML; Wu HY; Lin KM; Liu SC; Kuo HW; Chiang IC; Chen AC; Tian JN; Liu YL
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):695-703. PubMed ID: 22406240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk.
    Gemignani F; Landi S; Moreno V; Gioia-Patricola L; Chabrier A; Guino E; Navarro M; Cambray M; Capellà G; Canzian F
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1633-8. PubMed ID: 16030094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship among methadone dose, polymorphisms of dopamine D2 receptor and tri-dimensional personality questionnaire in heroin-addicted patients.
    Huang MW; Chiang TA; Lo PY; Huang CS
    Behav Brain Funct; 2016 Aug; 12(1):24. PubMed ID: 27580593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.